CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06913179 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06913179
- Sponsor
- Xuzhou Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2027-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.